CNC.NYSECentene CORP

Form 4: Centene Director Acquires 10,000 Shares in Open Market Transaction

Sentiment:

SEC Form 4 Filing


Centene director Christopher J. Coughlin purchased 10,000 shares of common stock at an average price of $59.44 on December 16, 2024.

Summary

  • Christopher J. Coughlin, a director at Centene Corp, acquired 10,000 shares of common stock on December 16, 2024.
  • The shares were purchased at a weighted average price of $59.44, with individual prices ranging from $59.43 to $59.44.
  • Following the transaction, Mr. Coughlin directly owns 36,357.926 shares of Centene, which includes 2,916 restricted stock units subject to vesting requirements.
  • Mr. Coughlin also holds options to purchase 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, to February 7, 2032.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director is generally seen as a positive sign, but it's a routine transaction and doesn't indicate a major shift in the company's outlook.

Positives

  • The director's purchase of shares could be seen as a positive signal of confidence in the company's future prospects.
  • The purchase increases the director's alignment with shareholder interests.

Industry Context

This transaction is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company directors.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
  • The purchase of shares by a director is a common occurrence and is not unusual in the context of corporate governance.
  • The reported transaction is similar to other Form 4 filings by directors of comparable companies.

Stakeholder Impact

  • The share purchase may have a minor positive impact on shareholder sentiment.
  • The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
12/16/2024Date of the share purchase transaction.
12/17/2024Date the Form 4 was signed.
02/07/2025Date the stock options become exercisable.
02/07/2032Expiration date of the stock options.

Keywords

Centene, Director, Share Purchase, Common Stock, Insider Trading, Form 4, Christopher J. Coughlin

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.